Avid Bioservices (CDMO) Misses Q4 EPS by 5c, Reaffirms Rev. Guidance
Avid Bioservices (NASDAQ: CDMO) reported Q4 EPS of ($0.08), $0.05 worse ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
